BCL2 and leukemia: MYBMIM led to MYB-p300 dissociation, suppression of MYB activity followed by downregulation of MYC and BCL2, apoptosis induction in AML cells, and prolonged survival in patient-derived MLL-rearranged leukemia mouse model[241].